AU5528198A - Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides - Google Patents

Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides

Info

Publication number
AU5528198A
AU5528198A AU55281/98A AU5528198A AU5528198A AU 5528198 A AU5528198 A AU 5528198A AU 55281/98 A AU55281/98 A AU 55281/98A AU 5528198 A AU5528198 A AU 5528198A AU 5528198 A AU5528198 A AU 5528198A
Authority
AU
Australia
Prior art keywords
vaccination
peptides
multiple sclerosis
against multiple
specific tcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55281/98A
Other languages
English (en)
Inventor
Steven W. Brostoff
Dennis J. Carlo
Daniel P. Gold
Lawrence R. Smith
Darcy B. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Response Corp
Sidney Kimmel Cancer Center
Original Assignee
Immune Response Corp
Sidney Kimmel Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp, Sidney Kimmel Cancer Center filed Critical Immune Response Corp
Publication of AU5528198A publication Critical patent/AU5528198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU55281/98A 1997-12-03 1997-12-03 Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides Abandoned AU5528198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/023147 WO1999027957A1 (fr) 1997-12-03 1997-12-03 Vaccination et procede de lutte contre la sclerose en plaques au moyen de peptides tcr vbeta specifiques

Publications (1)

Publication Number Publication Date
AU5528198A true AU5528198A (en) 1999-06-16

Family

ID=22262296

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55281/98A Abandoned AU5528198A (en) 1997-12-03 1997-12-03 Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides

Country Status (2)

Country Link
AU (1) AU5528198A (fr)
WO (1) WO1999027957A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
ES2478446T3 (es) 2003-06-27 2014-07-22 International Institute Of Cancer Immunology, Inc. Método de selección de pacientes candidatos para la vacuna contra WT1
EP3173480A3 (fr) 2007-03-05 2017-08-16 International Institute of Cancer Immunology, Inc. Gène du récepteur des lymphocytes t spécifiques de l'antigène du cancer, peptide codé par le gène et utilisation de ceux-ci
DK2281065T3 (en) * 2008-04-16 2015-10-05 Hudsonalpha Inst For Biotechnology PROCEDURE TO EVALUATE AND COMPARE IMMUNE REPERTOIRS
TWI548414B (zh) 2009-11-23 2016-09-11 庫比斯特製藥有限責任公司 達托黴素（ｄａｐｔｏｍｙｃｉｎ）組合物及相關方法
US9803246B2 (en) 2011-06-28 2017-10-31 International Institute Of Cancer Immunology, Inc. Receptor gene for peptide cancer antigen-specific T cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6464978B1 (en) * 1989-03-21 2002-10-15 The Immune Response Corporation Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
WO1993012814A2 (fr) * 1991-12-24 1993-07-08 The Immune Response Corporation Vaccination et procedes contre des maladies resultant de reponses pathogenes de populations de lymphocytes t specifiques

Also Published As

Publication number Publication date
WO1999027957A1 (fr) 1999-06-10

Similar Documents

Publication Publication Date Title
AU692612B2 (en) Peptide mixture and products thereof
AU1519499A (en) Interactive devices and methods
AU8591398A (en) Workflow systems and methods
AU8766098A (en) Assay methods and apparatus
AU7035698A (en) Test system and test method
AU4054697A (en) Mhc binding peptide oligomers and methods of use
AU6080898A (en) Factor x deletion mutants and analogues thereof
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU6280596A (en) Mycobacterium tuberculosis dna sequences encoding immunostimlatory peptides
AU1613799A (en) Improved depilatory method and device
AU9220898A (en) High inertia inductor-alternator apparatus and methods
AU3911897A (en) Phospholipase d and dna sequences
AU4236097A (en) Mhc peptides and methods of use
AU5528198A (en) Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides
AU4064897A (en) Mammalian ribonuclease inhibitors and use thereof
AU7238098A (en) Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants
AU3305197A (en) Non-activated receptor complex proteins and uses thereof
AU8752098A (en) Product-transferring apparatus and assembly comprising such product-transferringapparatus
AU2408397A (en) Ob protein receptor genes and use of the same
AU3288497A (en) Mammalian tolloid-like gene and protein
AU9357598A (en) Multipurpose display and support system
AU5851296A (en) Malaria peptides and vaccines
AU5218796A (en) Mailbox assembly and associated methods
AU7360298A (en) An apparatus for cleaning vinyl billboards and flex faces
AU8772598A (en) Dna encoding the human synapsin iii gene and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase